Scinogy


Provider of engineering, process and commercialization services for cell therapy manufacture. Focuses on design, prototyping and integration of closed, automated cell-processing systems, single-use consumables and counter-flow centrifugation technologies to support autologous and allogeneic cell therapy scale-up and commercial production.

Industries

biotechnology
manufacturing
medical-device

Nr. of Employees

small (1-50)

Scinogy

436 Elgar Road, Box Hill, VIC, Australia 3128


Products

Counter-flow centrifugation system for small-batch cell therapy processing

A small-footprint counter-flow centrifugation instrument designed for closed, automated separation, washing and concentration of cells to support research, early clinical and scalable manufacturing.

Single-use closed processing kits

Custom-configured single-use kits for closed processing workflows, designed to enable parallel batch processing and improve process robustness.


Services

Consulting services to select process technologies, define scale-up strategies and plan commercialization pathways for cell therapies.

End-to-end engineering, prototyping and testing of integrated closed systems for cell therapy production, including module integration and pilot systems.

Design of single-use kits and carriers for closed-process workflows, including barcode-enabled loading to support parallel processing and reduce errors.

Support for transferring prototypes to contract manufacturers and commercial partners to enable production scale-up and market entry.

Expertise Areas

  • Cell therapy manufacturing
  • Autologous and allogeneic process design
  • Closed-system automation
  • Manufacturing scale-up strategy
  • Show More (3)

Key Technologies

  • Counter-flow centrifugation
  • Closed automated cell-processing systems
  • Single-use consumable kits with 2D barcode traceability
  • Automated bag-mixing modules
  • Show More (3)

News & Updates

Displayed closed cell-processing technology at an industry conference (ISCT 2019) with a commercial partner.

Discussion of factors critical to successful commercialization of advanced therapies and the impact of early development decisions on later scale-up and cost.

Recognition in Australian Good Design Awards for a cell- and gene-therapy processing product in Product Design and Engineering Design categories.

Selection as a finalist in the R&D 100 Awards for an analytical/test category product.

Partnerships with contract manufacturers and a global biotechnology company to commercialize a cell-processing system and support scaled manufacture.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.